Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Overexpression of IL-32 is a novel prognostic factor in patients with localized clear cell renal cell carcinoma.

Lee HJ, Liang ZL, Huang SM, Lim JS, Yoon DY, Lee HJ, Kim JM.

Oncol Lett. 2012 Feb;3(2):490-496. Epub 2011 Dec 2.


Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.

Volpe A, Novara G, Antonelli A, Bertini R, Billia M, Carmignani G, Cunico SC, Longo N, Martignoni G, Minervini A, Mirone V, Simonato A, Terrone C, Zattoni F, Ficarra V; Surveillance and Treatment Update on Renal Neoplasms (SATURN) Project; Leading Urological No-Profit Foundation for Advanced Research (LUNA) Foundation.

BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.


NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.

Liang ZL, Kang K, Yoon S, Huang SM, Lim JS, Kim JM, Lim JS, Lee HJ.

Ann Surg Oncol. 2012 Aug;19(8):2763-72. doi: 10.1245/s10434-011-2204-3. Epub 2012 Jan 14.


Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis.

Li X, Ma X, Chen L, Gu L, Zhang Y, Zhang F, Ouyang Y, Gao Y, Huang Q, Zhang X.

Sci Rep. 2015 Aug 19;5:13157. doi: 10.1038/srep13157. Review.


Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.

Zhang Y, Sun B, Zhao X, Liu Z, Wang X, Yao X, Dong X, Chi J.

J Surg Oncol. 2013 Nov;108(6):414-9. doi: 10.1002/jso.23402. Epub 2013 Aug 29.


Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.

Harada K, Miyake H, Kusuda Y, Fujisawa M.

BJU Int. 2012 Dec;110(11 Pt C):E1131-7. doi: 10.1111/j.1464-410X.2012.11297.x. Epub 2012 Jun 19.


Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.

Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.

Cancer. 2005 Jun 15;103(12):2517-25.


Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.

Shim M, Song C, Park S, Kim A, Choi SK, Kim CS, Ahn H.

Ann Surg Oncol. 2015 Jan;22(1):344-50. doi: 10.1245/s10434-014-4153-0. Epub 2014 Oct 17.


Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.


Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma.

Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H.

J Clin Oncol. 2009 Oct 1;27(28):4709-17. doi: 10.1200/JCO.2008.18.9498. Epub 2009 Aug 31.


CD44 is an independent prognostic factor in conventional renal cell carcinomas.

Paradis V, Ferlicot S, Ghannam E, Zeimoura L, Blanchet P, Eschwége P, Jardin A, Benoît G, Bedossa P.

J Urol. 1999 Jun;161(6):1984-7.


Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.

Zhang ZL, Chen W, Li YH, Liu ZW, Luo JH, Lau W, Tan MH, Zhou FJ.

Chin J Cancer. 2011 Nov;30(11):772-8. doi: 10.5732/cjc.011.10085.


Prognostic value of clinical and pathological factors for surgically treated localized clear cell renal cell carcinoma.

Teng J, Gao Y, Chen M, Wang K, Cui X, Liu Y, Xu D.

Chin Med J (Engl). 2014;127(9):1640-4.


Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas.

Yao M, Murakami T, Shioi K, Mizuno N, Ito H, Kondo K, Hasumi H, Sano F, Makiyama K, Nakaigawa N, Kishida T, Nagashima Y, Yamanaka S, Kubota Y.

Cancer Med. 2014 Aug;3(4):845-54. doi: 10.1002/cam4.270. Epub 2014 May 26.


High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC.

Cancer. 2006 Jul 1;107(1):37-45.


Activated extracellular signal-regulated kinase is an independent prognostic factor in clinically confined renal cell carcinoma.

Campbell L, Nuttall R, Griffiths D, Gumbleton M.

Cancer. 2009 Aug 1;115(15):3457-67. doi: 10.1002/cncr.24389.


VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma.

Yao M, Yoshida M, Kishida T, Nakaigawa N, Baba M, Kobayashi K, Miura T, Moriyama M, Nagashima Y, Nakatani Y, Kubota Y, Kondo K.

J Natl Cancer Inst. 2002 Oct 16;94(20):1569-75.


High APOBEC3B expression is a predictor of recurrence in patients with low-risk clear cell renal cell carcinoma.

Xu L, Chang Y, An H, Zhu Y, Yang Y, Xu J.

Urol Oncol. 2015 Aug;33(8):340.e1-8. doi: 10.1016/j.urolonc.2015.05.009. Epub 2015 Jun 4.


Supplemental Content

Support Center